PROGRAM

Korea Standard Time
Local Time

Meeting Schedule

The Schedule is tentative and subject to change.

as of November 4, 2024

July 3 (Thursday)
Time/Room GBR 101 GBR 102 GBR 103 GBR 104 GBR 105 Rm. 205A Rm. 205B Rm. 209
08:40-08:50 Opening Remarks
08:50-10:30 SP 01
Cancer epigenetics and 3D chromatin epigenomics 		SP 02
Novel radiotherapy techniques 		SP 03
Antibody-drug conjugates and beyond: Exploring next-generation target therapeutics 		SP 04
Bridging OMICs and clinical data: Unlocking clinically relevant molecular insights using data science 		SP 05
Cancer burden attributable to risk factors 		Oral Presentaiton 1 Oral Presentaiton 2 To be announced
10:30-10:50 Break
10:50-11:30 Plenary Lecture 1
11:30-12:10 Plenary Lecture 2
12:10-12:30 Break
12:30-13:10 Luncheon Symposia
13:10-13:30 Break
13:30-15:10 JPK MLAOS Session Industry Corner SP 06
Cancer and microbiome		 SP 07
Harmonizing treatment for HPV related oropharyngeal carcinoma

*KCA-KSHNO

 SP 08
Geriatric oncology in East Asia: Trends, policies, and guidelines		 Oral Presentaiton 3 Oral Presentaiton 4 To be announced
15:10-15:30 Break
15:30-17:10

Overseas Asian Researcher Session

SP 09
Recent advances in ctDNA analysis

 SP 10
Cancer vaccine and engineered cell therapy		 SP 11
Multidisciplinary perspectives on perioperative immunotherapy in lung cancer

*KCA-CACA

 SP 12
Optimal patient-facing support into cancer trajectory

*KCA-AONS-KONS

 Oral Presentaiton 5 Oral Presentaiton 6 To be announced

▶ Poster Session 1: 09:00-17:00 (presentation: 12:40-13:30)

- (SP07) KSHNO: Korean Society for Head and Neck Oncology
- (SP11) CACA: China Anti-Cancer Association
- (SP12) AONS: Asia Oncology Nursing Society, KONS: Korean Oncology Nursing Society



July 4 (Friday)
Time/Room GBR 101 GBR 102 GBR 103 GBR 104 GBR 105 Rm. 205 Rm. 209
08:40-10:00 ES 1
Palliative management of malignant gastrointestinal obstruction 		ES 2
Clinical genomics: From basics to applications		 ES 3
Recent advance in cancer immunotherapy beyond PD-1 and CTLA-4		 ES 4
Advanced technologies in cancer research		 ES 5
Large language model and foundation AI in cancer research		 Oral Presentaiton 7 Oral Presentaiton 8
10:00-10:20 Break
10:20-11:00 Plenary Lecture 3
11:00-11:40 Plenary Lecture 4
11:40-12:00 Break
12:00-12:40 Luncheon Symposia
12:40-13:20 KCA General Assembly
13:30-15:10

Young Investigator Symposium

 SP 13
Cutting-edge translational research in GI malignancy

*KCA-JCA

 SP 14
Myeloid cell-derived immune evasion

*KCA-KAI

 SP 15
Dissecting tumor heterogeneity through single cell and spatial omicscancer

*KCA-KOGO

 SP 16
Advance in the diagnosis and management of vascular tumor

*KCA-KSPHO

 SP 17
Oligometastasis 		SP 18
암관련학회협의체 심포지엄
15:10-15:30 Break
15:30-17:10 SP 19
Publication and research communications 		SP 20
Enhancing outcomes for cancer survivors: Innovative interventions and strategies		 SP 21
Advanced cancer genomics

*KCA-CSI

 SP 22
Comprehensive strategies for hereditary cancer management 		SP 23
Optimal treatment strategy for locally advanced bladder cancer		 SP 24
Fertility preservation in cancer patients 		To be announced
17:10 Awards & Closing Ceremony

▶ Poster Session 2: 09:00-17:00 (presentation: 12:30-13:20)

- (SP13) JCA: Japanese Cancer Association
- (SP14) KAI: Korean Association of Immunologists
- (SP15) KOGO: Korea Genome Organization
- (SP16) KSPHO: Korean Society of Pediatric Hematology-Oncology
- (SP21) CSI: Cancer Science Institute of Singapore